Ocular Therapeutix
About:
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Website: http://www.ocutx.com
Twitter/X: ocutx
Top Investors: Perceptive Advisors, Baxter International, Polaris Partners, Deep Track Capital, Versant Ventures
Description:
Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.
$712M
$50M to $100M
Bedford, Massachusetts, United States
2006-01-01
info(AT)ocutx.com
Amarpreet Sawhney, Farhad Khosravi
251-500
2024-02-22
Public
© 2025 bioDAO.ai